Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF EXECUTIVE OFFICER

CEO of ImprimisRx

CHIEF FINANCIAL OFFICER

Chief Executive Officer

Chief Commercial Officer

Chief Financial Officer

President, ImprimisRx

Harrow Health, Inc., an eyecare pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies. The company offers ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic medicines, including IOPIDINE and MOXEZA; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and MAQ-100, a preservative-free triamcinolone acetonide ophthalmic injection drug candidate. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

Harrow Health, Inc., an eyecare pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapi...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-19	Premium	bought	Premium	Premium	Premium	-
2024-03-28	Premium	bought	Premium	Premium	Premium	-
2024-03-22	Premium	bought	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-03-20	Premium	bought	Premium	Premium	Premium	-
2024-03-01	Premium	acquired	Premium	Premium	Premium	CEO of ImprimisRx
2024-02-20	Premium	sold	Premium	Premium	Premium	CEO of ImprimisRx
2024-02-20	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-20	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-02-20	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-02-20	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-02-20	Premium	acquired	Premium	Premium	Premium	CEO of ImprimisRx
2024-02-07	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-02-07	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-11-16	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-11-15	Premium	bought	Premium	Premium	Premium	-
2023-11-10	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2023-11-10	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2023-09-20	Premium	bought	Premium	Premium	Premium	-
2023-09-19	Premium	bought	Premium	Premium	Premium	-
2023-08-14	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2023-08-14	Premium	bought	Premium	Premium	Premium	-
2023-07-18	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-07-18	Premium	sold (taxes)	Premium	Premium	Premium	Chief Commercial Officer
2023-07-18	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2023-07-18	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer

HROW - Harrow Health Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for HROW